Results 121 to 130 of about 15,139,370 (299)

Prevalence of Dietary Supplement Use and Potential Medication Interactions Among Adults With Systemic Lupus Erythematosus

open access: yesArthritis Care &Research, EarlyView.
Objective The aim of this study was to characterize the prevalence and correlates of dietary supplement use, identify commonly used supplements, and evaluate potential supplement–medication interactions among adults with systemic lupus erythematosus (SLE).
Sarah L. Patterson   +7 more
wiley   +1 more source

Small‐Bowel Capsule Endoscopy in Immune‐Mediated Enterocolitis: A Case Series of Four Patients

open access: yesJGH Open
Immune checkpoint inhibitors (ICIs) have emerged as a cornerstone of cancer immunotherapy but are associated with immune‐mediated adverse events (imAEs), including gastrointestinal toxicities.
Masayuki Orikasa   +11 more
doaj   +1 more source

Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors

open access: yesCurrent Oncology
The increased use of immune checkpoint inhibitors (ICIs) across cancer programs has created the need for standardized monitoring and management of immune-related adverse events (irAEs).
Parneet K. Cheema   +17 more
doaj   +1 more source

A Scoping Review and Meta‐Analysis of Proportions of Central Nervous System Manifestations Reported in Patients with Sjögren's Disease

open access: yesArthritis Care &Research, EarlyView.
Objective The objective of this scoping review was to synthesize evidence on the proportion of individuals living with Sjögren's disease who experience central nervous system (CNS) manifestations. Methods We searched MEDLINE (via PubMed) and Embase from 1980 through January 29, 2026, and the ECRI Guidelines Trust from 2020 through January 29, 2026 ...
Arun Varadhachary   +21 more
wiley   +1 more source

Immune Checkpoint Inhibitors and Cardiotoxicity: A Comparative Meta‐Analysis of Observational Studies and Randomized Controlled Trials

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Immune checkpoint inhibitors (ICIs) have uncommon associations with cardiotoxicity, yet these cardiotoxic effects are associated with high mortality.
Akash Sharma   +7 more
doaj   +1 more source

The Association of Gout Flare Resolution With Physical Activity and Sleep: A Prospective Remote‐Monitoring Study

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to determine whether gout flare resolution is associated with physical activity and sleep. These findings were intended to inform the future development of a definition for flare resolution. Methods Data from 81 participants with gout who experienced at least one flare during a six‐month prospective observational study were ...
Sarah Stewart   +12 more
wiley   +1 more source

Immune-Related Dermatologic Reactions in Cancer Patients Undergoing Immunotherapy: A Case Series

open access: yesIndian Journal of Medical and Paediatric Oncology
Immune checkpoint inhibitors (ICIs) have transformed the treatment paradigm across various malignancies by reactivating T cell responses against tumor cells.
Raja Chhabra   +5 more
doaj   +1 more source

Clinical and translational attributes of immune-related adverse events

open access: yesNature Cancer
With immune checkpoint inhibitors (ICIs) becoming the mainstay of treatment for many cancers, managing their immune-related adverse events (irAEs) has become an important part of oncological care. This Review covers the clinical presentation of irAEs and crucial aspects of reversibility, fatality and long-term sequelae, with special attention to irAEs ...
Karijn P. M. Suijkerbuijk   +3 more
openaire   +3 more sources

Immune-Related Adverse Events of Immune Checkpoint Inhibitors

open access: yes
Immune-Related Adverse Events of Immune Checkpoint Inhibitors. Charoo Iyer, Chief Resident, Rochester General Hospital Internal Medicine Residency Program; Chengu Niu, Chief Resident, Rochester General Hospital Internal Medicine Residency Program; Ido ...
Patel, Mehul   +3 more
core  

Oral glucocorticoids added to ILD‐modifying therapy in systemic sclerosis‐associated interstitial lung disease: a target trial emulation study from the EUSTAR database.

open access: yesArthritis Care &Research, Accepted Article.
Objectives We aimed to estimate whether adding oral glucocorticoids to ILD‐modifying therapy improves 12‐month lung outcomes in systemic sclerosis‐associated interstitial lung disease (SSc‐ILD). Methods We emulated a target trial using the EUSTAR database.
Zubeyir Salis   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy